Effect of nicardipine, a Ca2+ channel blocker, on pyruvate dehydrogenase activity and energy metabolites during cerebral ischemia and reperfusion in gerbil brain

Brain Research

Volumn 781, Issue 1-2, 1998, Pages 212-217

  Katayama, Yasuo ^a   Fukuchi, Takaharu ^a   McKee, Ann ^a   Terashi, Akiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Ca2+ channel blocker; Cerebral ischemia; Energy metabolites; Nicardipine; PDH activity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL BLOCKING AGENT; CREATINE PHOSPHATE; LACTIC ACID; NICARDIPINE; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; GERBIL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; ANIMAL; DRUG EFFECT; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; CALCIUM CHANNEL BLOCKERS; ENERGY METABOLISM; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; MALE; NICARDIPINE; PYRUVATE DEHYDROGENASE COMPLEX; REPERFUSION INJURY;

EID: 0032545530     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01246-8     Document Type: Article

References (48)

1. Alps B.J., Calder C., Haas W.K., Wilson A.D. Comparative protective effects of nicardipine, flunarizine, lidoflazine, and nimodipine against ischemic injury in the hippocampus of the Mongolian gerbil. Br. J. Pharmacol. 93:1988;877-883.
2. Alps B.J., Haas W.K. Nicardipine and phenytoin prevention of cerebral ischemic cell change in a new rat survival model of brief four vessel occlusion. Neurology. 35:1985;141. Suppl.
3. Anis N.A., Berry S.C., Burton N.R., Lodge D. The dissociative anaesthetics, ketamine and phenycyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79:1983;565-575.
4. Berger L., Hakim A.M. Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats. J. Cereb. Blood Flow Metab. 9:1989;58-64.
5. Bielenberg G.W., Beck T., Sauer D., Burniol M., Krieglstein J. Effects of cerebroprotective agents on cerebral blood flow and on post ischemic energy metabolism in the rat brain. J. Cereb. Blood Flow Metab. 7:1987;480-488.
6. Bielenberg G.W., Haubruck H., Krieglstein J. Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain. J. Cereb. Blood Flow Metab. 7:1987;489-496.
7. Carafoli E., Penniston J.T. The calcium signal. Sci. Am. 253(11):1985;50-58.
8. Cardell M., Koide T., Wieloch T. Pyruvate dehydrogenase activity in the rat cerebral cortex following cerebral ischemia. J. Cereb. Blood Flow Metab. 9:1989;350-357.
9. Damuni Z., Humphreys J.S., Reed L.J. Stimulation of pyruvate dehydrogenase activity by polyamines. Biochem. Biophys. Res. Commun. 124:1984;95-99.
10. Fiscum G. Involvement of mitochondria in ischemic cell injury and in regulation of intracellular calcium. Am. J. Emerg. Med. 1:1983;147-152.
11. Gelmers H.J., Gorter K., De Weerdt C.J., Wiezer H.J.A. A controlled trial of nimodipine in acute ischemic stroke. N. Engl. J. Med. 318:1988;203-207.
12. Ginsberg M.D., Welsh F.A., Budd W.W. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat: I. Local cerebral blood flow and glucose utilization. Stroke. 11:1980;347-354.
13. + exchange in lymphocytes by phorbol esters: changes in cytoplasmic pH dependence of the antiport. Proc. Natl. Acad. Sci. USA. 82:1985;1429-1433.
14. Hakim A.M. Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 6:1986;676-683.
15. Handa J., Yoneda S., Koyama T., Matsuda M., Handa H. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93. Surg. Neurol. 3:1975;195-199.
16. Hansen A.J., Zeuthen T. Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. Acta. Physiol. Scand. 113:1981;437-445.
17. Harris R., Symon L. Extracellular pH, potassium and calcium activities in progressive ischemia of rat cortex. J. Cereb. Blood Flow Metab. 4:1984;178-186.
18. Heffez D.S., Passonneau J.V. Effect of nimodipine on cerebral metabolism during ischemia and recirculation in the Mongolian gerbil. J. Cereb. Blood Flow Metab. 5:1985;523-528.
19. Hinman L.M., Blass J.P. An NADH-linked spectrophotometric assay for pyruvate dehydrogenase complex in crude tissue homogenates. J. Biol. Chem. 256:1981;6583-6586.
20. Jope R., Blass J.P. The regulation of pyruvate dehydrogenase in brain in vivo. J. Neurochem. 26:1976;709-714.
21. Katayama Y., Muramatsu H., Kamiya T., McKee A., Terashi A. Ischemic tolerance phenomenon from an approach of energy metabolism and the mitochondrial enzyme activity of pyruvate dehydrogenase in gerbils. Brain Res. 746:1997;126-132.
22. Katayama Y., Welsh F.A. Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J. Neurochem. 52:1989;1817-1822.
23. Katsura K.I., Kristián T., Smith M.L., Siesjö B.K. Acidosis induced by hypercapnia exaggerates ischemic brain damage. J. Cereb. Blood Flow Metab. 14:1994;243-250.
24. O.H. Lowry, J.V. Passonneau, A Flexible System of Enzymatic Analysis, Academic Press, New York, 1972, 291 pp.
25. Miller R.J. Multiple calcium channels and neuronal function. Science. 235:1987;46-52.
26. 2+ influx in the pathogenesis of delayed neuronal death after brief forebrain ischemia in gerbils. Brain Res. 613:1993;181-192.
27. Oishi M., Niimi T., Takagi S., Takeoka T., Seki T., Toyoda M., Gotoh F. Chemical control of cerebral circulation. J. Neurol. Sci. 36:1978;403-410.
28. P.J. Randle, Phosphorylation-dephosphorylation cycles and the regulation of fuel selection in mammals, in: W.R. Estabrook, P. Srere (Eds.), Current Topics in Cellular Regulation, Vol. 18, Academic Press, New York, 1981, pp. 107-129.
29. Rappaport Z.H., Young W., Flamm E. Regional brain calcium changes in the rat middle cerebral artery occlusion model of ischemia. Stroke. 18:1987;760-764.
30. L.J. Reed, Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle, in: W.R. Estabrook, P. Srere (Eds.), Current Topics in Cellular Regulation, Vol. 18, Academic Press, New York, 1981, pp. 95-106.
31. L. Reed, S.J. Yeaman, Pyruvate dehydrogenase, in: P.D. Boyer, E.G. Krebs (Eds.), The Enzymes, Vol. 18, Academic Press, New York, 1987, pp. 77-95.
32. Rehncrona S., Rosén I., Siesjö B.K. Excessive cellular acidosis: an important mechanism of neuronal damage in the brain? Acta Physiol. Scand. 110:1980;435-437.
33. Rehncrona S., Rosén I., Siesjö B.K. Brain lactic acidosis and ischemic cell damage: I. Biochemistry and neurophysiology. J. Cereb. Blood Flow Metab. 1:1981;297-311.
34. Siemkowicz E., Hansen A.J. Brain extracellular ion composition and EEG activity following 10 minutes ischemia in normo- and hyperglycemic rats. Stroke. 12:1981;236-240.
35. Sheu K.-F.R., Lai J.C.K., Blass J.P. Pyruvate dehydrogenase phosphate (PDHb) phosphatase in brain: activity, properties, and subcellular localization. J. Neurochem. 40:1983;1366-1372.
36. Sheu K.-F.R., Lai J.C.K., Blass J.P. Properties and regional distribution of pyruvate dehydrogenase kinase in rat brain. J. Neurochem. 42:1984;230-236.
37. Siesjö B.K. Mechanisms of ischemic brain damage. Crit. Care Med. 16:1988;954-963.
38. B.K. Siesjö, T. Wieloch, Brain ischemia and cellular calcium homeostasis, in: T. Godfraindt (Ed.), Calcium Entry Blockers and Tissue Protection, Raven Press, New York, 1985, pp. 139-149.
39. + in the hippocampus during recovery from short-term, transient ischemia. J. Cereb. Blood Flow Metab. 12:1992;759-772.
40. Steen P.A., Gisvold S.E., Milde J.H., Newberg L.A., Scheithauer B.W., Lanier W.L., Michenfelder J.D. Nimodipine improves outcome when given after complete ischemia in primates. Anesthesiology. 62:1985;406-414.
41. Takenaka T., Handa J. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys, and human patients. Int. J. Clin. Pharmacol. Biophys. 17:1979;1-11.
42. Takenaka T., Usuda S., Nomura T., Maeno H., Sado T. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93). Arzeneim.-Forsch. 26:1976;2172-2178.
43. Thayer S.A., Murphy S.N., Miller R.J. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system. Mol. Pharmacol. 30:1986;505-509.
44. Thompson A.M., West D.C., Lodge D. An N-methyl aspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature. 313:1985;479-481.
45. Uematsu D., Araki N., Greenberg J.H., Sladky J., Reivich M. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology. 41:1991;88-94.
46. Welsh F.A., Ginsberg M.D., Rieder W., Budd W.W. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat: II. Regional metabolic levels. Stroke. 11:1980;355-363.
47. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
48. Zaidan E., Sims N.R. The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J. Neurochem. 63:1994;1812-1819.